Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China

Clinical trial NCT03437837 · COMPLETED

Trial details

NCT number: NCT03437837
Sponsor: Peking University First Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Cancer Neoadjuvant Therapy Neoplasm Staging Estrogen Receptor Histological Grade HER2 Prognosis Predictive Value of Tests

Start date: 2017-05-01
Primary completion: 2018-09-29
Enrollment: 1077

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.